Consider Ezetimibe as a Statin Add-On
You'll continue to see LESS use of non-statins (niacin, etc) for dyslipidemia...due to limited evidence of CV benefit.
Consider discontinuing non-statins when patients are admitted if there's no good reason for the patient to be on them.
Use these tips to evaluate the need for non-statins.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote